Amgen

Amgen's marketing efforts help boost Tepezza sales
Fierce Pharma
Wed, 08/7/24 - 11:27 am
Amgen
earnings
Tepezza
Amgen revenue surges 20% to $8.4B while net income dips in Q2
Medical Marketing and Media
Tue, 08/6/24 - 05:55 pm
Amgen
earnings
Amgen’s Imdelltra BiTEs into SCLC treatment drought
Clinical Trials Arena
Sun, 07/14/24 - 10:15 pm
Amgen
Imdelltra
small cell lung cancer
BiTEs
Amgen Axes Development of Early-Stage Bispecific T-Cell Engager for Solid Tumors
BioSpace
Wed, 07/10/24 - 11:11 am
Amgen
T-cell engager
AMG 794
solid tumors
clinical trials
In boost to Amgen, analysts predict osteoporosis market share shift
Fierce Pharma
Fri, 06/28/24 - 11:28 am
Amgen
osteoporosis
Amgen’s Blincyto approved by FDA for new acute lymphoblastic leukaemia indication
PM Live
Mon, 06/17/24 - 10:28 pm
Amgen
FDA
Blincyto
acute lymphoblastic leukemia
Amgen's drug meets main goal in late-stage study for rare disease
Reuters
Wed, 06/5/24 - 11:03 am
Amgen
clinical trials
Uplinza
IgG4-RD
ASCO: Bristol Myers' KRAS confirmatory data avoid Amgen's flaws but leave FDA prospect unclear
Fierce Pharma
Sun, 06/2/24 - 02:51 pm
ASCO 2024
Bristol Myers Squibb
Amgen
KRAS inhibitors
Krazati
non-small cell lung cancer
FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters
Tue, 05/28/24 - 10:29 pm
Amgen
AstraZeneca
biosimilars
Soliris
Bkemv
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD
Fierce Pharma
Mon, 05/20/24 - 11:25 am
Amgen
AstraZeneca
COPD
Sanofi
Regeneron
Tezspire
Dupixent
In Big Pharma's growth rankings, Lilly took top spot from Novo Nordisk in Q1
Fierce Pharma
Thu, 05/16/24 - 09:51 pm
Big Pharma
Eli Lilly
Novo Nordisk
earnings
Amgen
FDA approves Amgen drug for small cell lung cancer
Reuters
Thu, 05/16/24 - 09:47 pm
Amgen
tarlatamab
FDA
small cell lung cancer
Winners and Losers in Biopharma’s Q1 2024 Earnings Season
BioSpace
Wed, 05/15/24 - 11:30 am
earnings
Amgen
AstraZeneca
Novo Nordisk
Biogen
Bristol Myers Squibb
JNJ
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
Amgen's new Horizon products bolster top line despite continued Tepezza struggles
Fierce Pharma
Fri, 05/3/24 - 11:23 am
Amgen
Horizon Pharma
Krystexxa
Tepezza
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters
Thu, 05/2/24 - 10:19 pm
Amgen
clinical trials
obesity
AMG786
MariTide
Amgen’s profit slides, revenue jumps in Q1
Medical Marketing and Media
Thu, 05/2/24 - 10:09 pm
Amgen
earnings
Amgen Highlights New COPD, Asthma and Vasculitis Research at ATS 2024
BioSpace
Wed, 05/1/24 - 09:31 am
Amgen
Tezspire
COPD
AMG104
severe asthma
Tavneos
vasculitits
R&D
ATS
Amgen CEO nabs pay raise thanks to Horizon deal. Does that incentivize aggressive M&A?
Fierce Pharma
Thu, 04/18/24 - 10:21 pm
Amgen
Pharma CEOs
Bob Bradway
executive compensation
Amgen, facing potential Enbrel price cap in Colorado, takes state's new drug affordability board to court
Fierce Pharma
Tue, 03/26/24 - 04:31 pm
Amgen
Enbrel
Medicare
Colorado
drug pricing

Pages